Global Peripheral Vascular Intervention Products Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Peripheral Vascular Intervention Products market size was valued at US$ 10800 million in 2024 and is forecast to a readjusted size of USD 17770 million by 2031 with a CAGR of 7.3% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Peripheral Vascular intervention refers to medical procedures performed to diagnose and treat conditions affecting the blood vessels outside the heart and brain, primarily the arteries and veins in the arms, legs, abdomen, and pelvis. These interventions are typically minimally invasive and are aimed at restoring or improving blood flow to the affected peripheral tissues. Peripheral intervention procedures include angioplasty, stenting, atherectomy, thrombectomy, embolization, and other techniques used to address various conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), venous insufficiency, aneurysms, and vascular malformations. These procedures are often performed by interventional radiologists, vascular surgeons, or cardiologists using catheter-based techniques guided by imaging modalities such as fluoroscopy, ultrasound, or computed tomography (CT). Peripheral intervention plays a crucial role in improving patient outcomes, relieving symptoms, preventing complications, and preserving limb function in individuals with peripheral vascular diseases.
The growth of the Peripheral Vascular Intervention (PVI) products market is primarily driven by the rising prevalence of peripheral artery disease (PAD), fueled by aging populations, increasing diabetes and obesity rates, and sedentary lifestyles. Advancements in minimally invasive technologies, such as drug-eluting balloons and bioresorbable stents, have also enhanced clinical outcomes and patient recovery times, further accelerating adoption. Additionally, growing awareness of early diagnosis and the expansion of healthcare infrastructure in emerging markets contribute to increasing demand for PVI products globally.
Despite strong growth prospects, the PVI products market faces challenges including high device costs and limited reimbursement in several regions, which can hinder access to treatment, particularly in low- and middle-income countries. Moreover, the market is highly competitive and regulated, requiring continuous innovation and clinical validation, which increases R&D expenditure. The risk of restenosis and procedural complications also remains a concern, potentially limiting the widespread adoption of some interventional techniques.
This report is a detailed and comprehensive analysis for global Peripheral Vascular Intervention Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Peripheral Vascular Intervention Products market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Peripheral Vascular Intervention Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Peripheral Vascular Intervention Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Peripheral Vascular Intervention Products market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peripheral Vascular Intervention Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peripheral Vascular Intervention Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BD, Biotronik, Boston Scientific, Medtronic, Merit Medical, Terumo, Teleflex, Cook Medical, Cordis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Peripheral Vascular Intervention Products market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Market segment by Application
Arterial Diseases
Venous Diseases
Major players covered
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Guichuangtongqiao
Xinmai Medical
Xenrad Medical
Xianjian Technology
Weigao Shares
Bomei Medical
Dingke Medical
Zhejiang Batai Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peripheral Vascular Intervention Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peripheral Vascular Intervention Products, with price, sales quantity, revenue, and global market share of Peripheral Vascular Intervention Products from 2020 to 2025.
Chapter 3, the Peripheral Vascular Intervention Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Vascular Intervention Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Peripheral Vascular Intervention Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peripheral Vascular Intervention Products.
Chapter 14 and 15, to describe Peripheral Vascular Intervention Products sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Peripheral Vascular intervention refers to medical procedures performed to diagnose and treat conditions affecting the blood vessels outside the heart and brain, primarily the arteries and veins in the arms, legs, abdomen, and pelvis. These interventions are typically minimally invasive and are aimed at restoring or improving blood flow to the affected peripheral tissues. Peripheral intervention procedures include angioplasty, stenting, atherectomy, thrombectomy, embolization, and other techniques used to address various conditions such as peripheral artery disease (PAD), deep vein thrombosis (DVT), venous insufficiency, aneurysms, and vascular malformations. These procedures are often performed by interventional radiologists, vascular surgeons, or cardiologists using catheter-based techniques guided by imaging modalities such as fluoroscopy, ultrasound, or computed tomography (CT). Peripheral intervention plays a crucial role in improving patient outcomes, relieving symptoms, preventing complications, and preserving limb function in individuals with peripheral vascular diseases.
The growth of the Peripheral Vascular Intervention (PVI) products market is primarily driven by the rising prevalence of peripheral artery disease (PAD), fueled by aging populations, increasing diabetes and obesity rates, and sedentary lifestyles. Advancements in minimally invasive technologies, such as drug-eluting balloons and bioresorbable stents, have also enhanced clinical outcomes and patient recovery times, further accelerating adoption. Additionally, growing awareness of early diagnosis and the expansion of healthcare infrastructure in emerging markets contribute to increasing demand for PVI products globally.
Despite strong growth prospects, the PVI products market faces challenges including high device costs and limited reimbursement in several regions, which can hinder access to treatment, particularly in low- and middle-income countries. Moreover, the market is highly competitive and regulated, requiring continuous innovation and clinical validation, which increases R&D expenditure. The risk of restenosis and procedural complications also remains a concern, potentially limiting the widespread adoption of some interventional techniques.
This report is a detailed and comprehensive analysis for global Peripheral Vascular Intervention Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Peripheral Vascular Intervention Products market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Peripheral Vascular Intervention Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Peripheral Vascular Intervention Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Peripheral Vascular Intervention Products market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peripheral Vascular Intervention Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peripheral Vascular Intervention Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BD, Biotronik, Boston Scientific, Medtronic, Merit Medical, Terumo, Teleflex, Cook Medical, Cordis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Peripheral Vascular Intervention Products market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Stent
Catheter
Guidewire
Sheath
Vena Cava Filter
Other
Market segment by Application
Arterial Diseases
Venous Diseases
Major players covered
Abbott
BD
Biotronik
Boston Scientific
Medtronic
Merit Medical
Terumo
Teleflex
Cook Medical
Cordis
Alvimedica
Lepu Medical
Guichuangtongqiao
Xinmai Medical
Xenrad Medical
Xianjian Technology
Weigao Shares
Bomei Medical
Dingke Medical
Zhejiang Batai Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peripheral Vascular Intervention Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peripheral Vascular Intervention Products, with price, sales quantity, revenue, and global market share of Peripheral Vascular Intervention Products from 2020 to 2025.
Chapter 3, the Peripheral Vascular Intervention Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peripheral Vascular Intervention Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Peripheral Vascular Intervention Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peripheral Vascular Intervention Products.
Chapter 14 and 15, to describe Peripheral Vascular Intervention Products sales channel, distributors, customers, research findings and conclusion.
Table of Contents
127 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Peripheral Vascular Intervention Products by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
